ON-DEMAND WEBINAR
Cellular Reprogramming of Cancer Cells to Antigen-presenting Cells for Immunotherapy
What you will learn in this webinar?
- Challenges and strategies in cancer immunotherapy, with a focus on addressing diverse patient indications.
- Cellular reprogramming and its potential to transform regenerative medicine.
- An innovative approach to reprogram cancer cells into dendritic cells to overcome immune evasion.
- Transformative potential of this therapy in the landscape of cancer immunotherapy and its broader applications.
SPEAKER
Filipe Pereira
Professor of Molecular Medicine at Lund University, Co-founder and Head of Innovation of Asgard Therapeutics
Takara Bio Europe
Dr. Filipe Pereira is a renowned molecular medicine expert, particularly in cellular reprogramming and hematopoietic research. He has made significant contributions to the field, including the induction of dendritic cells from non-hematopoietic cells. His pioneering work has led to prestigious awards, such as the ERC Consolidator Grant, making him a key figure in the advancement of regenerative medicine and cancer immunotherapy. |
 |
